Overexpression and gene amplification of BAG‐1L in hormone‐refractory prostate cancer

@article{Mki2007OverexpressionAG,
  title={Overexpression and gene amplification of BAG‐1L in hormone‐refractory prostate cancer},
  author={Hanna E M{\"a}ki and Outi R. Saramäki and Liubov Shatkina and Paula M. Martikainen and Teuvo L.J. Tammela and W M van Weerden and Robert L. Vessella and Andrew C B Cato and Tapio Visakorpi},
  journal={The Journal of Pathology},
  year={2007},
  volume={212}
}
BAG‐1L (Bcl‐2‐associated anthanogene 1) has been found to interact with androgen receptor (AR), and has been suggested to be involved in the development of prostate cancer. In order to determine the presence of genetic and/or expression alterations of BAG‐1L in prostate cancer, we analysed human prostate cancer cell lines and xenografts as well as patient samples of untreated, hormone‐naïve, and hormone‐refractory prostate carcinomas for sequence variations using denaturing high‐performance… Expand
The 9p13.3 amplicon in prostate cancer
TLDR
The most promising candidate target genes for gain at 9p13.3 are PIGO and UNC13B, but also CD72, VCP, GALT, DCTN3, C9orf25, UBAP2, RUSC2 and UBE2R2 cannot be excluded. Expand
Overexpression of Androgen Receptor in Prostate Cancer
TLDR
The findings suggest that the levels of AR potentiate the recruitment of the AR, as well as components of the basic transcription machinery, to chromatin and affect the acetylation of histones in the presence of low levels of androgens. Expand
Androgen receptor signaling pathway in prostate cancer
Androgen receptor (AR) is known to be overexpressed in castration-resistant prostate cancer. To interrogate the functional significance of the AR level, we established two LNCaP cell sublinesExpand
BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast
TLDR
Gene expression data demonstrated a consistent association between high BAG-1 mRNA and improved survival, which may reflect both a better definition of the hormone-responsive phenotype and a concurrent increased sensitivity to tamoxifen. Expand
Bag-1L: a promising therapeutic target for androgen receptor-dependent prostate cancer.
TLDR
Recent literature that suggest Bag-1L is a promising target for AR positive prostate cancer is reviewed, suggesting key molecules such as the co-chaperone Bag- 1L that bind to and enhance the activity of the AR AF-1. Expand
Bcl-2 associated anthanogen-1 (Bag-1) expression and prognostic value in pancreatic head and periampullary cancer.
TLDR
Bag-1 was present in the majority of both pancreatic head- and periampullary cancers, however it was only identified as a discriminator of outcome in Pancic head cancer. Expand
Designing of Anti-Cancer Drug Targeted to Bcl-2 Associated Athanogene (BAG1) Protein
Cancer is a disease of uncontrolled cell growth in tissues. This growth may lead to metastasis, which is the invasion of adjacent tissue and infiltration beyond the site of initiation. Cancer isExpand
Modulation of BAG-1 Expression Alters the Sensitivity of Breast Cancer Cells to Tamoxifen
TLDR
Up and down regulations of the BAG-1 expression were associated with the decreased and increased sensitivity to 4-OH TAM in the estrogen receptor-positive (ER+) human breast cancer cell line MCF-7 respectively, and distinct isoforms of B AG-1 had different anti-apoptotic ability in breast cancer cells treated with the 4- OH TAM. Expand
Molecular aspects of androgenic signaling and possible targets for therapeutic intervention in prostate cancer
TLDR
Although there has been an improvement of endocrine therapy in prostate cancer, increased intracrine ligand synthesis and appearance of variant receptors may facilitate the development of resistance. Expand
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer
TLDR
It is shown that the activation function-1 (AF-1) domain located in the N-terminus of the androgen receptor (AR) is bound by the cochaperone Bag- 1L, implicating Bag-1L as a potential therapeutic target in PCa. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 33 REFERENCES
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
TLDR
This work has identified a similar molecular mechanism in vivo for endocrine treatment failure in human prostate cancer which involves amplification of the androgen receptor (AR) gene. Expand
Expression of Androgen Receptor Coregulators in Prostate Cancer
TLDR
Findings suggest that the decreased expression of PIAS1 and SRC1 could be involved in the progression of prostate cancer. Expand
Alterations of androgen receptor in prostate cancer
  • M. Linja, T. Visakorpi
  • Medicine, Biology
  • The Journal of Steroid Biochemistry and Molecular Biology
  • 2004
TLDR
It has now become clear that prostate carcinomas emerging during the androgen withdrawal therapy are capable of reactivating the AR-mediated signalling despite of the low levels of androgens. Expand
Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model, CWR22-R
TLDR
Evolution of androgen-independent growth and proliferation, represented by CWR22-R, was associated with a reentry into active cell cycle and the up-regulation of several genes that were expressed at low levels or absent in the androgens-dependent tumor, and implies that evolution to androgen -independence is due, in part, to reactivation of theandrogen-response pathway in the absence of androgens. Expand
Genetic aberrations in prostate cancer by microarray analysis
TLDR
The combined expression and copy number analysis suggested that even a low‐level copy number change may have significant effect on gene expression, and thus on the development of prostate cancer. Expand
Molecular determinants of resistance to antiandrogen therapy
Using microarray-based profiling of isogenic prostate cancer xenograft models, we found that a modest increase in androgen receptor mRNA was the only change consistently associated with theExpand
BAG-1L Protein Enhances Androgen Receptor Function*
TLDR
BAG-1L significantly reduced the concentrations of 5α-dihydrotestosterone required for AR activity but did not induce ligand-independent transactivation, and markedly improved the ability of AR to transactivate reporter genes when cells were cultured with DHT in combination with the anti-androgen cyproterone acetate. Expand
Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.
TLDR
TopoIIalpha gene amplification and deletion are common in ErbB-2-amplified breast cancer and are associated with increased or decreased sensitivity to topoII inhibitors in vitro, respectively. Expand
HGF receptor associates with the anti‐apoptotic protein BAG‐1 and prevents cell death.
TLDR
The finding of a link between growth factor receptors and the anti‐apoptotic machinery fills a gap in the understanding of the molecular events regulating programmed cell death. Expand
Human BAG-1/RAP46 protein is generated as four isoforms by alternative translation initiation and overexpressed in cancer cells
TLDR
Deletion, site-directed mutagenesis and in vitro transcription/translation analysis showed that the four protein products of hBAG-1 were expressed by alternative initiation from four different start codons through a leaky scanning mechanism, suggesting that hBAGs is expressed as four forms of protein products, which may play a differential role in apoptosis and oncogenesis of human cells. Expand
...
1
2
3
4
...